You have 9 free searches left this month | for more free features.

City

Seongnam (2)

Seoul (1)

Condition

Type 2 Diabetes (2)

Type 2 Diabetes Mellitus (1)

Overall Status

Completed (2)

Recruiting (1)

Sign in for free

Phase

phase 4 (2)

phase 1 (1)

Sponsor

Seoul National University Bundang Hospital (2)

Chong Kun Dang Pharmaceutical (1)

Collaborator

Intervention

lobeglitazone (3)

dapagliflozin (1)

glimepirde (1)

metformin (1)

pioglitazone (1)

sitagliptin (1)

warfarin (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (3)

lobeglitazone

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Type 2 Diabetes Trial in Seongnam (Sitagliptin, Dapagliflozin, Lobeglitazone)

Completed

Type 2 Diabetes

Sitagliptin
+4 more

Seongnam, Gyeonggi, Korea, Republic of

Soo Lim

Jan 2, 2022

Type 2 Diabetes Trial in Seongnam (Pioglitazone, Lobeglitazone)

Recruiting

Type 2 Diabetes

Pioglitazone
Lobeglitazone

Seongnam, Gyeonggi, Korea, Republic of

Seoul National University Bundang Hospital

Mar 29, 2021

Type 2 Diabetes Trial in Seoul (Lobeglitazone, Warfarin)

Completed

Type 2 Diabetes Mellitus

Lobeglitazone
Warfarin

Seoul, Korea, Republic of

Samsung Medical Center

Jul 1, 2014